These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2192153)

  • 21. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
    Kallenberg CG; Pastoor GW; Wouda AA; The TH
    Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 23. [Detection of antinuclear antibodies of the anticentromere antibody type].
    Kühn G; Jarzabek-Chorzelska M; Chorzelski TP
    Dermatol Monatsschr; 1988; 174(1):43-7. PubMed ID: 3128456
    [No Abstract]   [Full Text] [Related]  

  • 24. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
    Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
    Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of anticentromere antibody in idiopathic Raynaud's syndrome.
    Sarkozi J; Bookman AA; Lee P; Keystone EC; Fritzler MJ
    Am J Med; 1987 Nov; 83(5):893-8. PubMed ID: 3314499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
    Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies.
    Beutner EH; Krasny SA; Chorzelski TP; Rodnan G; Jablonska S; Kumar V
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):289-95. PubMed ID: 3882784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Active chronic hepatitis with incomplete CREST syndrome: value of anticentromere antibodies].
    Devars du Mayne JF; Yeni P; Harlé X; Chagnon JP; Boulanger F; Brion N
    Gastroenterol Clin Biol; 1982 Nov; 6(11):949. PubMed ID: 6983991
    [No Abstract]   [Full Text] [Related]  

  • 30. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
    Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
    Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
    Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
    Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Antinuclear antibodies-clinical significance of the nuclear immunofluorescent patterns.
    Burnham TK; Bank PW
    Am J Clin Pathol; 1975 Aug; 64(2):289-90. PubMed ID: 1098444
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mixed connective tissue disease in pediatrics].
    Arroyave-Hernández CM; Goldaracena F; Gortazar P; Mejía S
    Bol Med Hosp Infant Mex; 1982 Mar; 39(3):169-75. PubMed ID: 7046761
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA; Rice JR; Bembe ML; Barada FA
    Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 36. [The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions].
    Sato S; Takehara K; Ishibashi Y
    Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):97-104. PubMed ID: 2072581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinucleolar antibodies. Their frequency and diagnostic association.
    Ritchie RF
    N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acrosclerosis, Gougerot-Sjögren syndrome, myxedema and anti-centromere antibodies. 3 cases of this association].
    Balafrej M; Kahn MF; Vigneron AM; Bourgeois P
    Ann Med Interne (Paris); 1987; 138(3):185-8. PubMed ID: 3497597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.